Drug-like index: a new approach to measure drug-like compounds and their diversity.
about
Proteochemometric modeling of the bioactivity spectra of HIV-1 protease inhibitors by introducing protein-ligand interaction fingerprintPredicting mTOR inhibitors with a classifier using recursive partitioning and Naïve Bayesian approachesAdvances in Nuclear Magnetic Resonance for Drug Discovery.Screening of selective histone deacetylase inhibitors by proteochemometric modeling.A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat.Discrimination of approved drugs from experimental drugs by learning methodsMulti-target QSAR modelling in the analysis and design of HIV-HCV co-inhibitors: an in-silico study.Global analysis of large-scale chemical and biological experiments.Integrated QSAR study for inhibitors of Hedgehog Signal Pathway against multiple cell lines:a collaborative filtering methodInvestigations on inhibitors of hedgehog signal pathway: a quantitative structure-activity relationship studyPrediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.MolDIA: XML based system of molecular diversity analysis towards virtual screening and QSPR.Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines.Computational medicinal chemistry in fragment-based drug discovery: what, how and when.Potassium channels: structures, diseases, and modulators.Hierarchical strategy for identifying active chemotype classes in compound databases.Rule-Based Classification of Chemical Structures by Scaffold.A de novo substructure generation algorithm for identifying the privileged chemical fragments of liver X receptorβ agonists.A General, Simple Catalyst for Enantiospecific Cross Couplings of Benzylic Ammonium Triflates and Boronic Acids: No Phosphine Ligand RequiredQuantifying the chemical beauty of drugs.Toward a general predictive QSAR model for gamma-secretase inhibitors.Novel Mcl-1/Bcl-2 dual inhibitors created by the structure-based hybridization of drug-divided building blocks and a fragment deconstructed from a known two-face BH3 mimetic.In Silico ADME/Tox PredictionsUnderstanding drug-likenessImpact of Microbial Natural Products on Antibacterial Drug Discovery
P2860
Q28481635-BC1BA413-6137-4063-B329-E5D791BF9184Q28538732-98E21000-8F7F-4D02-9156-79D2658CE634Q30387229-1DEA220A-1920-4D9D-B257-E0B077B66433Q30420578-10369192-8C22-4EEC-AB92-BBAD6BF1F45BQ33819340-0276B19B-1564-4012-A1BE-EA01DE815189Q33899201-3366596D-FDDB-4629-8B25-C58A20694F82Q33966485-9267E3EA-E7C9-4EAC-9DF3-AD238BA955B2Q34314326-C0998DB5-4EDB-4005-9A6A-8BCB877A3A1BQ34360426-759D7711-1647-4828-9789-2377539FBA3BQ35048554-83A40B1C-3754-4864-9D0A-468DBD4ED36DQ36043183-7DD69DFD-16E3-4C79-AAA3-B7D74B56700DQ36412141-04B8DDA5-EC6D-4BDC-BA92-9F7353613295Q36513179-8F681709-EFF0-4211-B57F-A16F50AC3D13Q37856296-DBDDEEB5-9012-4A34-ABD4-F7C8316D3435Q38151974-A7555B20-020B-471E-BAD2-28D2B9279587Q38404992-98A112FE-FE20-4D6F-8A9D-7C5ABCD08D8FQ38487191-21EA5841-1A05-427F-BDB3-3B8DF8CB8994Q41326213-6A0F69A3-EA1B-41E4-A5B5-0C4EA9597C24Q42181224-67DC4C6C-3FCB-484F-85C8-785D26563ED7Q42414958-0421082E-A47A-449F-A1C4-92C70B881B35Q51047535-DC3643B4-9382-43A5-A327-945814AF7951Q52970803-5BA55250-98C9-4B7D-8EEB-2F7E36843F2BQ56984194-59604331-6688-4436-93AE-195E70248CA3Q57016955-6189883C-50CB-4A40-9E1A-889A525C008FQ57936466-6380286E-2325-4CF6-8CA8-92F9B56C43C2
P2860
Drug-like index: a new approach to measure drug-like compounds and their diversity.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Drug-like index: a new approach to measure drug-like compounds and their diversity.
@ast
Drug-like index: a new approach to measure drug-like compounds and their diversity.
@en
type
label
Drug-like index: a new approach to measure drug-like compounds and their diversity.
@ast
Drug-like index: a new approach to measure drug-like compounds and their diversity.
@en
prefLabel
Drug-like index: a new approach to measure drug-like compounds and their diversity.
@ast
Drug-like index: a new approach to measure drug-like compounds and their diversity.
@en
P356
P1476
Drug-like index: a new approach to measure drug-like compounds and their diversity.
@en
P2093
P304
P356
10.1021/CI000026+
P577
2000-09-01T00:00:00Z